Showing results (11-20 of 266) with videos related to
Sort By:
Pageof 27
Journal of Inherited Metabolic Disease|August 29, 2014
The consequences of genetic and pharmacologic reduction in sphingolipid synthesisRaphael SchiffmannActa Neurologica Belgica|August 11, 2006
Neuropathy and Fabry disease: pathogenesis and enzyme replacement therapyRaphael SchiffmannJournal of Inherited Metabolic Disease|April 23, 2025
Role of Biomarkers in Diagnosing Disease, Assessing the Severity and Progression of Disease, and Evaluating the Efficacy of TherapiesRaphael SchiffmannKidney International|August 26, 2004
Parapelvic kidney cysts: a distinguishing feature with high prevalence in Fabry diseaseMarkus Ries, Karen E Bove Bettis, Peter Choyke, et al.Journal of Clinical Pharmacology|August 19, 2007
Enzyme replacement in Fabry disease: pharmacokinetics and pharmacodynamics of agalsidase alpha in children and adolescentsMarkus Ries, Joe T Clarke, Catharina Whybra, et al.Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry diseaseDavid F Moore, Ehud Goldin, Monique P Gelderman, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2006
Quantitative dysmorphology assessment in Fabry diseaseMarkus Ries, David F Moore, Chevalia J Robinson, et al.Muscle & Nerve|April 4, 2006
Enzyme replacement therapy and intraepidermal innervation density in Fabry diseaseRaphael Schiffmann, Peter Hauer, Barbara Freeman, et al.BMC Neurology|November 8, 2008
Skin-impedance in Fabry Disease: a prospective, controlled, non-randomized clinical studySurya N Gupta, Markus Ries, Gary J Murray, et al.Pageof 27